Magnus Ingelman-Sundberg
Karolinska Institutet
H-index: 128
Europe-Sweden
Top articles of Magnus Ingelman-Sundberg
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
What is the Current Clinical Impact of the CYP2CTG Haplotype? | Clinical Pharmacology and Therapeutics | Magnus Ingelman-Sundberg Marin Jukić Line Skute Bråten Marianne Kristiansen Kringen Espen Molden | 2023 |
Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment | Magnus Ingelman‐Sundberg Munir Pirmohamed | 2024/2/11 | |
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6‐catalyzed metabolism of solanidine | Clinical and Translational Science | Robert Løvsletten Smith Birgit M Wollmann Elisabet Størset Hasan Çağın Lenk Kevin S O'Connell | 2024/2 |
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized … | Filip Milosavljević Espen Molden Magnus Ingelman-Sundberg Marin M Jukić | 2024/4/1 | |
Pharmacogenomics beyond single common genetic variants: the way forward | Volker M Lauschke Yitian Zhou Magnus Ingelman-Sundberg | 2024/1/23 | |
Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response | Magnus Ingelman‐Sundberg Espen Molden | 2024/3/24 | |
Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model | Scientific Reports | Sara Redenšek Trampuž Sander van Riet Åsa Nordling Magnus Ingelman-Sundberg | 2024/1/16 |
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model | Hepatology Communications | Sander van Riet Anais Julien Andrea Atanasov Åsa Nordling Magnus Ingelman-Sundberg | 2024/3/1 |
Individualized pharmacotherapy utilizing genetic biomarkers and novel in vitro systems as predictive tools for optimal drug development and treatment | Drug Metabolism and Disposition | Magnus Ingelman-Sundberg Volker M Lauschke | 2024/1/1 |
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism | British Journal of Clinical Pharmacology | Birgit M Wollmann Robert L Smith Marianne Kristiansen Kringen Magnus Ingelman‐Sundberg Espen Molden | 2024/3 |
The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia | Neuropathology and Applied Neurobiology | Filip Milosavljević Irene Brusini Andrea Atanasov Marina Manojlović Marija Vučić | 2023/2 |
The role of CTGF in liver fibrosis induced in 3D human liver spheroids | Cells | Sara Redenšek Trampuž Sander van Riet Åsa Nordling Magnus Ingelman-Sundberg | 2023/1/13 |
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling | Magnus Ingelman-Sundberg Daniel W Nebert Volker M Lauschke | 2023/11/24 | |
drug mEtABoliSm And PErSonAlizEd thErAPy | Adrián Llerena Vangelis G Manolopoulos Mongi Benjeddou Bing Chen Jaroslav Hubacek | 2023 | |
Mechanistic, Functional, and Clinical Aspects of Pro‐inflammatory Cytokine Mediated Regulation of ADME Gene Expression in 3D Human Liver Spheroids | Clinical Pharmacology & Therapeutics | Katharina Klöditz Eida Tewolde Åsa Nordling Magnus Ingelman‐Sundberg | 2023/9 |
Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits | Clinical and Translational Science | Hasan Çağın Lenk Robert Løvsletten Smith Kevin S O'Connell Marin M Jukić Marianne Kristiansen Kringen | 2023/1 |
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress | Ron HN Van Schaik Vangelis G Manolopoulos Ann K Daly Mikko Niemi Branka Zukic | 2023/4 | |
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study | The Lancet | Jesse J Swen Cathelijne H van der Wouden Lisanne EN Manson Heshu Abdullah-Koolmees Kathrin Blagec | 2023/2/4 |
Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids | Cells | Chris S Pridgeon Dian P Bolhuis Filip Milosavljević Marina Manojlović Ákos Végvári | 2022/5/10 |
Response to Rowland et al. and Achour et al. | Clinical Pharmacology & Therapeutics | Chris S Pridgeon Inger Johansson Magnus Ingelman‐Sundberg | 2022/12/1 |
